Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 28Neoplasms 10Overweight 8Breast Neoplasms 7Dyspnea 6Sexual Dysfunction, Physiological 5Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Motor Activity 3Diabetes Mellitus, Type 2 3Weight Loss 2Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Leukemia 2Insulin Resistance 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Cough 2Constipation 2Colorectal Neoplasms 2Vomiting 1Ulcer 1

Interventions

naldemedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Other × 90 days × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡